Mammalian son of sevenless Guanine nucleotide exchange factors: old concepts and new perspectives.
暂无分享,去创建一个
[1] J. Seidman,et al. Activation of multiple signaling pathways causes developmental defects in mice with a Noonan syndrome–associated Sos1 mutation. , 2010, The Journal of clinical investigation.
[2] Shuang Huang,et al. Integrity of SOS1/EPS8/ABI1 tri-complex determines ovarian cancer metastasis. , 2010, Cancer research.
[3] X. Coumoul,et al. Induction of the Ras activator Son of Sevenless 1 by environmental pollutants mediates their effects on cellular proliferation. , 2010, Biochemical pharmacology.
[4] A. V. van Kessel,et al. Noonan syndrome, the SOS1 gene and embryonal rhabdomyosarcoma , 2010, Genes, chromosomes & cancer.
[5] D. Bar-Sagi,et al. Allosteric gating of Son of sevenless activity by the histone domain , 2010, Proceedings of the National Academy of Sciences.
[6] Jodi Gureasko,et al. Role of the histone domain in the autoinhibition and activation of the Ras activator Son of Sevenless , 2010, Proceedings of the National Academy of Sciences.
[7] B. Gelb,et al. Noonan Syndrome: Clinical Aspects and Molecular Pathogenesis , 2010, Molecular Syndromology.
[8] H. Hasle. Malignant Diseases in Noonan Syndrome and Related Disorders , 2009, Hormone Research in Paediatrics.
[9] J. Rhim,et al. Enhanced expression of SOS1 is detected in prostate cancer epithelial cells from African-American men. , 2009, International journal of oncology.
[10] Ravi Iyengar,et al. Mutation in SHOC2 promotes aberrant protein N-myristoylation and underlies Noonan-like syndrome with loose anagen hair , 2009, Nature Genetics.
[11] J. Allanson,et al. Multiple giant cell lesions in patients with Noonan syndrome and cardio-facio-cutaneous syndrome , 2009, European Journal of Human Genetics.
[12] J. Downward,et al. Many faces of Ras activation. , 2008, Biochimica et biophysica acta.
[13] M. Loh,et al. SOS1 mutations are rare in human malignancies: Implications for Noonan syndrome patients , 2008, Genes, chromosomes & cancer.
[14] Michael J Ackerman,et al. Gain-of-function RAF1 mutations cause Noonan and LEOPARD syndromes with hypertrophic cardiomyopathy , 2007, Nature Genetics.
[15] X. Coumoul,et al. The aryl hydrocarbon receptor, more than a xenobiotic‐interacting protein , 2007, FEBS letters.
[16] S. Jang,et al. Germ Line Gain of Function with SOS1 Mutation in Hereditary Gingival Fibromatosis* , 2007, Journal of Biological Chemistry.
[17] D. Horn,et al. SOS1 is the second most common Noonan gene but plays no major role in cardio-facio-cutaneous syndrome , 2007, Journal of Medical Genetics.
[18] F. Cañada,et al. Modification and activation of Ras proteins by electrophilic prostanoids with different structure are site-selective. , 2007, Biochemistry.
[19] D. Bar-Sagi,et al. Phospholipase D2-generated phosphatidic acid couples EGFR stimulation to Ras activation by Sos , 2007, Nature Cell Biology.
[20] M. Moschovi,et al. Rhabdomyosarcoma in a patient with Noonan syndrome phenotype and review of the literature. , 2007, Journal of pediatric hematology/oncology.
[21] N. Martínez,et al. Grb2 is a negative modulator of the intrinsic Ras-GEF activity of hSos1. , 2006, Molecular biology of the cell.
[22] H. Hosaka,et al. Targeting AMAP1 and cortactin binding bearing an atypical src homology 3/proline interface for prevention of breast cancer invasion and metastasis. , 2006, Proceedings of the National Academy of Sciences of the United States of America.
[23] Kam Y. J. Zhang,et al. Germline KRAS mutations cause Noonan syndrome , 2006, Nature Genetics.
[24] Holger Sondermann,et al. Structural Analysis of Autoinhibition in the Ras Activator Son of Sevenless , 2004, Cell.
[25] Kyle Steenland,et al. Dioxin Revisited: Developments Since the 1997 IARC Classification of Dioxin as a Human Carcinogen , 2004, Environmental health perspectives.
[26] D. Matallanas,et al. Activation of H-Ras in the Endoplasmic Reticulum by the RasGRF Family Guanine Nucleotide Exchange Factors , 2004, Molecular and Cellular Biology.
[27] Holger Sondermann,et al. Tandem histone folds in the structure of the N-terminal segment of the ras activator Son of Sevenless. , 2003, Structure.
[28] Sreenath V. Sharma,et al. Synthetic inhibitors of proline-rich ligand-mediated protein-protein interaction: potent analogs of UCS15A. , 2003, Chemistry & biology.
[29] F. Cañada,et al. The cyclopentenone 15-deoxy-Δ12,14-prostaglandin J2 binds to and activates H-Ras , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[30] Andre Hoelz,et al. Structural Evidence for Feedback Activation by Ras·GTP of the Ras-Specific Nucleotide Exchange Factor SOS , 2003, Cell.
[31] Xavier de la Cruz,et al. hSos1 Contains a New Amino-terminal Regulatory Motif with Specific Binding Affinity for Its Pleckstrin Homology Domain* , 2002, The Journal of Biological Chemistry.
[32] K. Miura,et al. Light Chain 3 associates with a Sos1 guanine nucleotide exchange factor: its significance in the Sos1-mediated Rac1 signaling leading to membrane ruffling , 2002, Oncogene.
[33] M. Caligiuri,et al. RasGRP4 Is a Novel Ras Activator Isolated from Acute Myeloid Leukemia* , 2002, The Journal of Biological Chemistry.
[34] J. Rojas,et al. Ras Genes and Human Cancer: Different Implications and Different Roles , 2002 .
[35] Mary L Marazita,et al. A mutation in the SOS1 gene causes hereditary gingival fibromatosis type 1. , 2002, American journal of human genetics.
[36] Sreenath V. Sharma,et al. UCS15A, a novel small molecule, SH3 domain-mediated protein–protein interaction blocking drug , 2002, Oncogene.
[37] Giorgio Scita,et al. Mechanisms through which Sos-1 coordinates the activation of Ras and Rac , 2002, The Journal of cell biology.
[38] J. Hancock,et al. The Linker Domain of the Ha-Ras Hypervariable Region Regulates Interactions with Exchange Factors, Raf-1 and Phosphoinositide 3-Kinase* , 2002, The Journal of Biological Chemistry.
[39] G. Scita,et al. An effector region in Eps8 is responsible for the activation of the Rac-specific GEF activity of Sos-1 and for the proper localization of the Rac-based actin–polymerizing machine , 2001, The Journal of cell biology.
[40] J Kuriyan,et al. Structure-based Mutagenesis Reveals Distinct Functions for Ras Switch 1 and Switch 2 in Sos-catalyzed Guanine Nucleotide Exchange* , 2001, The Journal of Biological Chemistry.
[41] Sreenath V. Sharma,et al. UCS15A, a non-kinase inhibitor of Src signal transduction , 2001, Oncogene.
[42] J. Rojas,et al. The isoform-specific stretch of hSos1 defines a new Grb2-binding domain , 2000, Oncogene.
[43] J. Ward,et al. Ras-Guanine Nucleotide Exchange Factor Sos2 Is Dispensable for Mouse Growth and Development , 2000, Molecular and Cellular Biology.
[44] Fiona M. Watt,et al. The EGF Receptor Provides an Essential Survival Signal for SOS-Dependent Skin Tumor Development , 2000, Cell.
[45] P. Sternberg,et al. Caenorhabditis elegans SOS‐1 is necessary for multiple RAS‐mediated developmental signals , 2000, The EMBO journal.
[46] D. Lowy,et al. The Sos1 and Sos2 Ras‐specific exchange factors: differences in placental expression and signaling properties , 2000, The EMBO journal.
[47] C. Betsholtz,et al. EPS8 and E3B1 transduce signals from Ras to Rac , 1999, Nature.
[48] J. Rojas,et al. Isoform-specific insertion near the Grb2-binding domain modulates the intrinsic guanine nucleotide exchange activity of hSos1 , 1999, Oncogene.
[49] D. Cussac,et al. A Sos‐derived peptidimer blocks the Ras signaling pathway by binding both Grb2 SH3 domains and displays antiproliferative activity , 1999, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[50] C. Der,et al. Regulation of RasGRP via a Phorbol Ester-Responsive C1 Domain , 1998, Molecular and Cellular Biology.
[51] Marius Sudol,et al. From Src Homology domains to other signaling modules: proposal of the `protein recognition code' , 1998, Oncogene.
[52] John Kuriyan,et al. The structural basis of the activation of Ras by Sos , 1998, Nature.
[53] J. Stone,et al. RasGRP, a Ras guanyl nucleotide- releasing protein with calcium- and diacylglycerol-binding motifs. , 1998, Science.
[54] D. Bowtell,et al. Activation of Ras and its downstream extracellular signal-regulated protein kinases by the CDC25 homology domain of mouse Son-of-sevenless 1 (mSos1) , 1998, Oncogene.
[55] D. Lowy,et al. N Terminus of Sos1 Ras Exchange Factor: Critical Roles for the Dbl and Pleckstrin Homology Domains , 1998, Molecular and Cellular Biology.
[56] D. Bar-Sagi,et al. Regulation of Sos Activity by Intramolecular Interactions , 1998, Molecular and Cellular Biology.
[57] D. Bar-Sagi,et al. Coupling of Ras and Rac guanosine triphosphatases through the Ras exchanger Sos. , 1998, Science.
[58] D. Lowy,et al. The Ras-specific exchange factors mouse Sos1 (mSos1) and mSos2 are regulated differently: mSos2 contains ubiquitination signals absent in mSos1 , 1997, Molecular and cellular biology.
[59] D. Bar-Sagi,et al. The Solution Structure of the Pleckstrin Homology Domain of Human SOS1 , 1997, The Journal of Biological Chemistry.
[60] S. Grant,et al. A role for the Ras signalling pathway in synaptic transmission and long-term memory , 1997, Nature.
[61] L. Cantley,et al. A Comparative Analysis of the Phosphoinositide Binding Specificity of Pleckstrin Homology Domains* , 1997, The Journal of Biological Chemistry.
[62] Julian Downward,et al. EGF induced SOS phosphorylation in PC12 cells involves P90 RSK-2 , 1997, Oncogene.
[63] A. Wittinghofer,et al. The interaction of Ras with GTPase‐activating proteins , 1997, FEBS letters.
[64] D. Bowtell,et al. The solution structure of the pleckstrin homology domain of mouse Son-of-sevenless 1 (mSos1). , 1997, Journal of molecular biology.
[65] M. Boechat,et al. Noonan syndrome associated with neuroblastoma: a case report , 1997, Pediatric Radiology.
[66] H. Mott,et al. Structural and functional analysis of a mutant Ras protein that is insensitive to nitric oxide activation. , 1997, Biochemistry.
[67] B. Chait,et al. A molecular redox switch on p21(ras). Structural basis for the nitric oxide-p21(ras) interaction. , 1997, The Journal of biological chemistry.
[68] D. Bowtell,et al. Mutation in Sos1 dominantly enhances a weak allele of the EGFR, demonstrating a requirement for Sos1 in EGFR signaling and development. , 1997, Genes & development.
[69] A. Wittinghofer,et al. How Ras-related proteins talk to their effectors. , 1996, Trends in biochemical sciences.
[70] Marshall Cj,et al. P21RAS ACTIVATION BY THE GUANINE NUCLEOTIDE EXCHANGE FACTOR SOS, REQUIRES THE SOS/GRB2 INTERACTION AND A SECOND LIGAND-DEPENDENT SIGNAL INVOLVING THE SOS N-TERMINUS , 1996 .
[71] X. de la Cruz,et al. A 15 amino acid stretch close to the Grb2-binding domain defines two differentially expressed hSos1 isoforms with markedly different Grb2 binding affinity and biological activity. , 1996, Oncogene.
[72] D. Zimonjic,et al. Expression of alternative forms of Ras exchange factors GRF and SOS1 in different human tissues and cell lines. , 1996, Oncogene.
[73] Robertag . Williams,et al. Noonan syndrome and neuroblastoma. , 1995, Archives of pediatrics & adolescent medicine.
[74] Anirvan Ghosh,et al. Calcium activation of Ras mediated by neuronal exchange factor Ras-GRF , 1995, Nature.
[75] D. Cussac,et al. The Grb2 adaptor , 1995, FEBS letters.
[76] E. Fisher,et al. The Grb2 binding domain of mSos1 is not required for downstream signal transduction , 1995, Nature Genetics.
[77] U. Banerjee,et al. In vivo functional analysis of the Ras exchange factor son of sevenless. , 1995, Science.
[78] S. F. Pearce,et al. Nitric Oxide-stimulated Guanine Nucleotide Exchange on p21ras(*) , 1995, The Journal of Biological Chemistry.
[79] S. Schreiber,et al. Two binding orientations for peptides to the Src SH3 domain: development of a general model for SH3-ligand interactions. , 1995, Science.
[80] F. Richards,et al. Critical residues in an SH3 domain from Sem-5 suggest a mechanism for proline-rich peptide recognition , 1994, Nature Structural Biology.
[81] Hongtao Yu,et al. Structural basis for the binding of proline-rich peptides to SH3 domains , 1994, Cell.
[82] A. Cherniack,et al. Phosphorylation of the Ras nucleotide exchange factor son of sevenless by mitogen-activated protein kinase. , 1994, The Journal of biological chemistry.
[83] Mark S. Boguski,et al. Proteins regulating Ras and its relatives , 1993, Nature.
[84] R. Weinberg,et al. The pathway to signal achievement , 1993, Nature.
[85] M. Baudry,et al. Localization of the cellular expression pattern of cdc25NEF and ras in the juvenile rat brain. , 1993, Brain research. Molecular brain research.
[86] J. Schlessinger,et al. How receptor tyrosine kinases activate Ras. , 1993, Trends in biochemical sciences.
[87] T Pawson,et al. SH2 and SH3 domains , 1993, Current Biology.
[88] M. Wigler,et al. Human Sos1: a guanine nucleotide exchange factor for Ras that binds to GRB2. , 1993, Science.
[89] F. McCormick. How receptors turn Ras on , 1993, Nature.
[90] Nanxin Li,et al. Guanine-nucleotide-releasing factor hSos1 binds to Grb2 and links receptor tyrosine kinases to Ras signalling , 1993, Nature.
[91] T. Pawson,et al. The SH2 and SH3 domains of mammalian Grb2 couple the EGF receptor to the Ras activator mSos1 , 1993, Nature.
[92] D. Bowtell,et al. Identification of murine homologues of the Drosophila son of sevenless gene: potential activators of ras. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[93] E. Martegani,et al. Cloning by functional complementation of a mouse cDNA encoding a homologue of CDC25, a Saccharomyces cerevisiae RAS activator. , 1992, The EMBO journal.
[94] G. Rubin,et al. Ras1 and a putative guanine nucleotide exchange factor perform crucial steps in signaling by the sevenless protein tyrosine kinase , 1991, Cell.
[95] R. Gorlin,et al. Noonan-like/multiple giant cell lesion syndrome. , 1991, American journal of medical genetics.
[96] U. Banerjee,et al. Genetic dissection of a neurodevelopmental pathway: Son of sevenless functions downstream of the sevenless and EGF receptor tyrosine kinases , 1991, Cell.
[97] J. Noonan. Hypertelorism with Turner phenotype. A new syndrome with associated congenital heart disease. , 1968, American journal of diseases of children.
[98] Shuang Huang,et al. Tumor and Stem Cell Biology Integrity of SOS 1 / EPS 8 / ABI 1 Tri-Complex Determines Ovarian Cancer Metastasis , 2010 .
[99] Ana Mª Fernández. Asociación Española contra el Cáncer , 2010 .
[100] Ravi Iyengar,et al. Mutation of SHOC2 promotes aberrant protein N-myristoylation and causes Noonan-like syndrome with loose anagen hair , 2009 .
[101] Michiko Furutani,et al. Germline gain-of-function mutations in RAF1 cause Noonan syndrome , 2007, Nature Genetics.
[102] Li Li,et al. Germline gain-of-function mutations in SOS1 cause Noonan syndrome , 2007, Nature Genetics.
[103] H. Hosaka,et al. Targeting AMAP 1 and cortactin binding bearing an atypical src homology 3 proline interface for prevention of breast cancer invasion and metastasis , 2006 .
[104] D. Bar-Sagi,et al. Autoinhibition of Sos by intramolecular interactions. , 2002, Frontiers in bioscience : a journal and virtual library.
[105] C. Marshall,et al. p21Ras activation by the guanine nucleotide exchange factor Sos, requires the Sos/Grb2 interaction and a second ligand-dependent signal involving the Sos N-terminus. , 1996, Oncogene.
[106] J. Downward,et al. Control of ras activation. , 1996, Cancer surveys.
[107] S. Schreiber,et al. Grb2 SH3 binding to peptides from Sos: evaluation of a general model for SH3-ligand interactions. , 1995, Chemistry & biology.
[108] M. Mattei,et al. Chromosomal localization of two genes encoding human ras exchange factors: SOS1 maps to the 2p22-->p16 region and SOS2 to the 14q21-->q22 region of the human genome. , 1994, Cytogenetics and cell genetics.
[109] J. Rhim,et al. Enhanced expression of SOS 1 is detected in prostate cancer epithelial cells from African-American men , 2022 .